Currently, there are 205.64M common shares owned by the public and among those 185.15M shares have been available to trade.
The company’s stock has a 5-day price change of -5.22% and -26.25% over the past three months. ZETA shares are trading 130.61% year to date (YTD), with the 12-month market performance up to 137.89% higher. It has a 12-month low price of $7.84 and touched a high of $38.20 over the same period. ZETA has an average intraday trading volume of 7.78 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.63%, -21.64%, and -0.04% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Zeta Global Holdings Corp (NYSE: ZETA) shares accounts for 64.16% of the company’s 205.64M shares outstanding.
It has a market capitalization of $4.83B and a beta (3y monthly) value of 1.12. The earnings-per-share (ttm) stands at -$0.70. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.33% over the week and 9.38% over the month.
Earnings per share for the fiscal year are expected to increase by 148.90%, and 31.57% over the next financial year. EPS should grow at an annualized rate of 38.15% over the next five years, compared to -42.41% over the past 5-year period.
Looking at the support for the ZETA, a number of firms have released research notes about the stock. Goldman stated their Neutral rating for the stock in a research note on December 11, 2024, with the firm’s price target at $30. KeyBanc Capital Markets was of a view on October 22, 2024 that the stock is Overweight, while Barclays gave the stock Equal Weight rating on October 18, 2024, issuing a price target of $28. Morgan Stanley on their part issued Equal-Weight rating on August 01, 2024.
